- Home
- TWO vs ATRC Comparison
TWO vs ATRC Comparison
Compare TWO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- ATRC
- Stock Information
- Founded
- TWO 2009
- ATRC 2000
- Country
- TWO United States
- ATRC United States
- Employees
- TWO N/A
- ATRC N/A
- Industry
- TWO Real Estate Investment Trusts
- ATRC Medical/Dental Instruments
- Sector
- TWO Real Estate
- ATRC Health Care
- Exchange
- TWO Nasdaq
- ATRC Nasdaq
- Market Cap
- TWO 1.1B
- ATRC 1.6B
- IPO Year
- TWO 2009
- ATRC 2005
- Fundamental
- Price
- TWO $10.32
- ATRC $30.72
- Analyst Decision
- TWO Buy
- ATRC Strong Buy
- Analyst Count
- TWO 8
- ATRC 10
- Target Price
- TWO $13.07
- ATRC $49.50
- AVG Volume (30 Days)
- TWO 2.2M
- ATRC 399.6K
- Earning Date
- TWO 07-29-2025
- ATRC 07-29-2025
- Dividend Yield
- TWO 17.53%
- ATRC N/A
- EPS Growth
- TWO N/A
- ATRC N/A
- EPS
- TWO N/A
- ATRC N/A
- Revenue
- TWO $370,696,000.00
- ATRC $480,076,000.00
- Revenue This Year
- TWO N/A
- ATRC $14.63
- Revenue Next Year
- TWO N/A
- ATRC $12.62
- P/E Ratio
- TWO N/A
- ATRC N/A
- Revenue Growth
- TWO N/A
- ATRC 15.79
- 52 Week Low
- TWO $10.16
- ATRC $20.20
- 52 Week High
- TWO $14.28
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- TWO 40.74
- ATRC 39.22
- Support Level
- TWO $10.23
- ATRC $31.00
- Resistance Level
- TWO $10.55
- ATRC $32.44
- Average True Range (ATR)
- TWO 0.23
- ATRC 1.03
- MACD
- TWO -0.00
- ATRC -0.09
- Stochastic Oscillator
- TWO 13.22
- ATRC 8.65
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.